Concepedia

Publication | Open Access

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

DOIFull Paper Access

203

Citations

18

References

2015

Year

Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, Masashi Kono, Hirokazu Chishina, Masahiro Takita, Satoshi Kitai, Tatsuo Inoue, Norihisa Yada, Satoru Hagiwara,
Liver Cancer

Abstract

Conversion to sorafenib significantly improves the OS in patients refractory to TACE therapy with intermediate-stage HCC. Administration of sorafenib is therefore recommended in such circumstances of TACE treatment failure.

References

YearCitations

Page 1